Mutation Clinical Trial
Official title:
Integrative Sequencing In Germline and Hereditary Tumours
This study will investigate the utility of integrative sequencing of individuals and families at risk of hereditary cancer syndromes and will uncover novel contributors to tumourigenesis. Integrative sequencing refers to: 1. Whole genome sequencing (WGS) of the germline (inherited) genome 2. Whole exome sequencing (WES) or targeted/panel sequencing of tumour(s) (somatic, tumour-specific mutations) 3. DNA methylation (methylome) analysis of tumour(s) 4. RNA sequencing (transcriptome) of tumour(s) Eligible patients receiving genetic care at Princess Margaret Cancer Centre and the University Health Network may be approached by their genetic counsellor for participation in this study.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03902353 -
Screening of Pulmonary Veino Occlusive Disease in Heterozygous EIF2AK4 Mutation Carriers
|
N/A | |
| Recruiting |
NCT03246841 -
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
|
N/A | |
| Completed |
NCT04068961 -
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism
|
||
| Recruiting |
NCT05954442 -
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
|
Phase 3 | |
| Active, not recruiting |
NCT04983628 -
Molecular Profiling in Prostate Cancer
|
||
| Recruiting |
NCT05446155 -
BioMEL- Diagnostic and Prognostic Factors in Melanoma.
|
||
| Completed |
NCT02612350 -
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
|
||
| Recruiting |
NCT05311709 -
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
|
Phase 2 | |
| Completed |
NCT02884063 -
Utilizing Free DNA in Embryo Culture for PGT
|
||
| Completed |
NCT02808715 -
Identification and Metabolic Characterization of a Cohort of Human Subjects With Mutations in PRDM-16
|
N/A | |
| Recruiting |
NCT05848271 -
Natural History Study of Patients With HPDL Mutations
|
||
| Enrolling by invitation |
NCT04708639 -
Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients
|
||
| Recruiting |
NCT03125759 -
The Association of Omentin and Ischemic Stroke
|
N/A | |
| Recruiting |
NCT05162508 -
Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease
|
||
| Recruiting |
NCT03786575 -
Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer
|
N/A | |
| Completed |
NCT05864937 -
C677T Methylenetetrahydrofolate Reductase Mutation
|
||
| Recruiting |
NCT03702309 -
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
|